IMVT — Immunovant, Inc. stock price, charts and financials

QT59Immunovant, Inc.

Immunovant, Inc. (NASDAQ: IMVT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
36.95
-0.70-1.86%
OverviewShort InterestFilings
IMVTQT59Immunovant, Inc.·NASDAQ
36.95-1.86%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 03, 20268-KCurrent report
Aug 28, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 22, 2026ARSAnnual report to shareholders
Jul 22, 2026DEF 14ADefinitive proxy statement
Jul 22, 2026DEFA14AAdditional proxy soliciting materials
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
#1 / 25 of 394
Page
▼
/ 16